BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Duality Biologics (Suzhou) Co. Ltd. (“DualityBio”), a clinical-stage biotech company focusing on the discovery and development of next generation […]
10 January 2023 Acquisition to enable creation of a fully integrated, enterprise-wide capability to discover, design and develop next-generation immunotherapies at scale by leveraging artificial […]
• Responds to growing global demand for biosafety testing as essential requirement for drug development and commercialization • Expansion creates more than 500 new jobs […]
Bulletin on Drug Safety – Current Issue 3/2022 Published The Bulletin on Drug Safety is a cooperation between the Federal Institute for Drugs and Medical […]
Immune Biosolutions Inc., a clinical-stage company, is pleased to announce that its leading biological drug candidate maintains a potent activity in neutralization assays. Recent results […]
Mr. Anthony J. Giovinazzo joins as Executive Chairman; and Dr. Nickolay V. Kukekov, Ph.D. as President and CEO KalGene also announced that concurrent with the […]
Clofamizine, a drug used to treat leprosy, is effective against SARS-CoV-2 infection in human cells and hamsters, according to a study published Tuesday in the […]
On the occasion of the International Day against Drug Abuse and Illicit Trafficking, Vice-President for Promoting our European Way of Life Margaritis Schinas said: “Drug […]
Summary: On Wednesday, March 25, 2020, from 3 pm – 4 pm Eastern Time, the U.S. Food and Drug Administration (FDA) will host a virtual […]
Copyright © 2023 | WordPress Theme by MH Themes
